Biodesix, Inc. (BDSX)
Total Valuation
Biodesix has a market cap or net worth of $117.29 million. The enterprise value is $99.37 million.
| Market Cap | 117.29M |
| Enterprise Value | 99.37M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Biodesix has 30.78 million shares outstanding. The number of shares has increased by 10,026.71% in one year.
| Shares Outstanding | 30.78M |
| Shares Change (YoY) | +10,026.71% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 80.13% |
| Owned by Institutions (%) | 15.82% |
| Float | 6.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| PB Ratio | 7.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 1.87.
| Current Ratio | 2.48 |
| Quick Ratio | 2.22 |
| Debt / Equity | 1.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -115.30%, which is considered low. The company has a ROIC of -96.20%.
| Return on Equity (ROE) | -115.30% |
| Return on Assets (ROA) | -32.10% |
| Return on Capital (ROIC) | -96.20% |
| Revenue Per Employee | $371,555 |
| Profits Per Employee | -$172,050 |
| Employee Count | 200 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.09% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -86.09% |
| 50-Day Moving Average | 4.87 |
| 200-Day Moving Average | 7.61 |
| Average Volume (30 Days) | 162,001 |
Short Selling Information
| Short Interest | 422,445 |
| Short % of Shares Out | 1.37% |
| Short % of Float | 6.41% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, Biodesix had revenue of $74.31 million and -34.41 million in losses. Earnings per share was -$1.36.
| Revenue | 74.31M |
| Gross Profit | 31.63M |
| Operating Income | -30.43M |
| Net Income | -34.41M |
| EBITDA | -27.64M |
| EBIT | -30.69M |
| Earnings Per Share (EPS) | -$1.36 |
Balance Sheet
The company has $47.91 million in cash and $30.00 million in debt, giving a net cash position of $17.92 million or $0.58 per share.
| Cash & Cash Equivalents | 47.91M |
| Total Debt | 30.00M |
| Net Cash | 17.92M |
| Net Cash Per Share | $0.58 |
| Book Value | 16.03M |
| Book Value Per Share | 0.52 |
| Working Capital | 33.66M |
Cash Flow
In the last 12 months, operating cash flow was -$26.78 million and capital expenditures -$2.45 million, giving a free cash flow of -$29.23 million.
| Operating Cash Flow | -26.78M |
| Capital Expenditures | -2.45M |
| Free Cash Flow | -29.23M |
| FCF Per Share | n/a |
Margins
Gross margin is 42.57%, with operating and profit margins of -40.95% and -46.31%.
| Gross Margin | 42.57% |
| Operating Margin | -40.95% |
| Pretax Margin | n/a |
| Profit Margin | -46.31% |
| EBITDA Margin | -37.20% |
| EBIT Margin | -41.30% |
| FCF Margin | -39.34% |
Dividends & Yields
Biodesix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -29.34% |
| FCF Yield | -24.92% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |